ArticleJournal of managed care & specialty pharmacy2015

Cost-Effectiveness of Pazopanib Versus Sunitinib for Renal Cancer in the United States.

Agnes Benedict et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.